Search
for

    Sort by

    Research 31–60 of 1000+

    1. 1726: Risk Decrease of Intra-Operative Bleeding During TURP with the Uptake of Finasteride: Evaluation of VEGF and CD34 The Journal of Urology · 2007
    2. Current treatment of BPH Biomedicine & pharmacotherapy · 1995 · 11 citations
    3. Key Clinical Trials in BPH 2002 · 4 citations
    4. Finasteride as a Neo-Adjuvant Treatment for TURPLiterature Review Journal of urology and nephrology open access · 2016
    5. Lower Urinary Tract Symptoms in Men JAMA · 2025
    6. Clinical Analysis of Parkinson's Disease with Urinary Bladder Dysfunction:A Report of 64 Cases Chinese Journal of General Practice · 2011
    7. Clinics in diagnostic imaging (221) Singapore Medical Journal · 2024
    8. Dutasteride: A Review of its Use in the Management of Prostate Disorders Clinical medicine insights · 2011 · 2 citations
    9. Combined oral contraceptives promote androgen receptor and oestrogen receptor alpha upregulation in the female prostate (Skene’s paraurethral glands) of adult gerbils (Meriones unguiculatus) Reproduction, Fertility and Development · 2018 · 3 citations
    10. Re: Can Long-Term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention? The Journal of Urology · 2017 · 1 citations
    11. UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood Urology · 2011
    12. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    13. Acute urinary retention: risks and management. PubMed · 2005 · 46 citations
    14. Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia. The Journal of Urology · 2005
    15. The Effect of Finasteride on the Expression of Vascular Endothelial Growth Factor and Microvessel Density: A Possible Mechanism for Decreased Prostatic Bleeding in Treated Patients The Journal of Urology · 2003 · 90 citations
    16. Telocytes of the male reproductive system: dynamic tissue organizers Frontiers in Cell and Developmental Biology · 2024 · 8 citations
    17. Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis European journal of medical research · 2026
    18. Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study Clinical Therapeutics · 1999 · 23 citations
    19. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    20. Clinical Pearls in Men's Health Mayo Clinic Proceedings · 2010 · 1 citations
    21. 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond European Urology Supplements · 2006 · 2 citations
    22. Endocrine treatment of benign prostatichypertrophy: Current concepts Urology · 1991 · 11 citations
    23. Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model Al Mustansiriyah Journal of Pharmaceutical Sciences · 2023 · 2 citations
    24. The Effect of Finasteride in Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1992 · 1040 citations
    25. What do we know about phytotherapy of benign prostatic hyperplasia? Life Sciences · 2015 · 67 citations
    26. Association of Benign Prostatic Hyperplasia with Male Pattern Baldness Urology · 1998 · 54 citations
    27. Prostate cancer update: 2007 Current Opinion in Oncology · 2008 · 6 citations
    28. Prostate cancer update: 2007 Current Opinion in Internal Medicine · 2008
    29. Abiraterone and spironolactone in prostate cancer: a combination to avoid Acta Clinica Belgica · 2018 · 9 citations
    30. Effect of the ethanol extract of Syzygium aromaticum (clove) leaves on the lipid profile and body weight in testosterone-induced benign prostatic hyperplasia rats Global Translational Medicine · 2026